Results 11 to 20 of about 49,719 (230)

Determinants of discordant immune response in a cohort of human immunodeficiency virus-infected patients initiating antiretroviral therapy

Sahel Medical Journal, 2020
Background: The introduction and wide use of highly active antiretroviral therapy (HAART) have significantly resulted in decline in morbidity and mortality from human immunodeficiency virus (HIV) infection and its related complications.
Abdullahi Umar, Mufutau Muphy Oripelaye, Fatai Olatunde Olanrewaju, Olaniyi Onayemi, Olayinka Abimbola Olasode, Olumayowa Abimbola Oninla   +5 more
doaj   +1 more source

Dental caries status of children receiving Highly active antiretroviral therapy (HAART) - A multicentric cross-sectional study in Tamil Nadu, India

Journal of Family Medicine and Primary Care, 2020
Background: Highly active antiretroviral therapy (HAART) has progressively improved the life expectancies in HIV positive children. These antiretroviral drugs could possibly have an influence on the oral health status.
G Shanmugavadivel, A R Senthil Eagappan, S Dinesh, A Balatandayoudham, M Sadish, P Prasanna Kumar   +5 more
doaj   +1 more source

Associated oral manifestations with HIV southeastern Brazilian patients on antiretroviral therapy

Brazilian Journal of Otorhinolaryngology, 2023
Objectives: This study aimed to assess the prevalence of oral lesions in patients living with HIV infection and their association with CD4 count, viral load, and antiretroviral therapy in patients with HIV.
Brisa Ketrine Lustosa de Souza, Daniele Sorgatto Faé, Cleidiel Aparecido Araújo Lemos, Francielle Silvestre Verner, Renato Assis Machado, Rose Mara Ortega, Sibele Nascimento de Aquino   +6 more
doaj   +1 more source

Highly Active Antiretroviral Therapy (HAART) [PDF]

Journal of Ethiopian Medical Practice, 2015
Highly active antiretroviral therapy (HAART) is a treatment strategy for HIV (human immunodeficiency virus)-infected patients that consists of administering three or more different drugs, including nucleoside reverse transcriptase inhibitors, protease inhibitors, and non-nucleoside reverse transcriptase inhibitors.
Daniel Thomas Ginat, Pamela Whitney Schaefer   +1 more
openaire   +3 more sources

Highly active antiretroviral therapy [PDF]

BMJ, 2004
The barriers to providing highly active antiretroviral therapy (HAART) in poor countries have until recently seemed insurmountable. The cited problems have ranged from weak health systems and poor infrastructure to inadequate numbers of health professionals. In reality, the main barrier has been the very high cost of antiretroviral drugs.
openaire   +2 more sources

Panhypopituitarism in HIV patient receiving antiretroviral therapy

Russian Open Medical Journal, 2021
The article is dedicated to a clinical case of the panhypopituitarism development in a patient with HIV infection receiving antiretroviral therapy. The number of HIV-infected patients worldwide has increased significantly over the past decades.
Tatyana B. Morgunova, Ekaterina S. Maloletkina, Ilya I. Amergulov, Irina V. Glinkina, Maria G. Pavlova, Valentin V. Fadeyev   +5 more
doaj   +1 more source

HAART (Highly Active Anti-Retroviral Therapy) : An overview

Journal of Marine Medical Society, 2014
Highly Active Anti - Retroviral Therapy (HAART) is a triple combination of ART drugs and is a n effective tool to control disease progression in HIV disease.
Praful Pande, Vivek Hande
doaj   +1 more source

Duration of Highly Active Antiretroviral Therapy Regimens [PDF]

Clinical Infectious Diseases, 2003
The median duration of highly active antiretroviral therapy (HAART) regimens was reported to be 11.8 months in one US study, but that study included both treatment-experienced and treatment-naive patients. The duration of initial HAART regimens for treatment-naive patients alone has not been reported.
Ray Y, Chen, Andrew O, Westfall, Michael J, Mugavero, Gretchen A, Cloud, James L, Raper, Ashlee G, Chatham, Edward P, Acosta, Kelly H, Taylor, Jerome, Carter, Michael S, Saag   +9 more
openaire   +2 more sources

Antiretroviral agents against human immunodeficiency virus

DST, 2022
Introduction: Since its discovery in the 1980s, the human immunodeficiency virus (HIV) has been the target of many studies. Nowadays, estimates show that 36.7 million people are infected with HIV worldwide.
Ingrid Barcelos de Oliveira, Claudio Cesar Cirne Santos, Izabel Christina Nunes de Palmer Paixão, Caroline de Souza Barros, Rosa Teixeira Pinho   +4 more
doaj  

TB co-infection and associated factors among HIV patients attending highly active antiretroviral therapy in Saint Peter's TB Specialized Hospital, Ethiopia: a five years retrospective study [PDF]

Afr Health Sci
Getaw D, Tigu F.
europepmc   +3 more sources